Absence of known feline MYH7 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy

被引:3
|
作者
O'Donnell, K. [1 ]
Adin, D. [1 ]
Atkins, C. E. [1 ]
DeFrancesco, T. [1 ]
Keene, B. W. [1 ]
Tou, S. [1 ]
Meurs, K. M. [1 ]
机构
[1] North Carolina State Univ, Coll Vet Med, Dept Vet Clin Sci, A227,1060 William Moore Dr, Raleigh, NC 27607 USA
关键词
cardiomyopathy; feline; genetic; HCM; mutation;
D O I
10.1111/age.13074
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Hypertrophic cardiomyopathy (HCM) is the most common cause of heart disease in the domestic cat with a genetic predisposition in a few breeds. In the Maine Coon and Ragdoll breeds, two variants associated with the HCM phenotype have been identified in the cardiac myosin binding protein C gene (MYBPC3; p.Ala31Pro and p.Arg820Trp respectively), and a single variant has been identified in the myosin heavy chain gene (MYH7; p.Glu1883Lys) in one domestic cat with HCM. It is not known if these variants influence the development of HCM in other cohorts of the feline population. The objective of this study was to evaluate the presence of the known MYBPC3 and MYH7 variants in a population of cats with HCM. DNA was isolated from samples collected from non-Ragdoll and non-Maine Coon domestic cats diagnosed with HCM through the North Carolina State University College of Veterinary Medicine and genotyped for the three variants. One-hundred and three DNA samples from cats with HCM were evaluated from domestic shorthair, domestic longhair and purebred cats. All samples were wt for the MYBPC3 and MYH7 variants. Although this study was limited by its inclusion of cats from one tertiary hospital, the lack of these MYBPC3 and MYH7 variants in this feline HCM population indicates that the clinical utility of genetic testing for these variants may be isolated to the two cat breeds in which these variants have been identified. Further studies to identify the causative variants for the feline HCM population are warranted.
引用
收藏
页码:542 / 544
页数:3
相关论文
共 50 条
  • [21] EARLY FUNCTIONAL STRAIN DIFFERENCES IN PRE-HYPERTROPHIC CARRIERS WITH MUTATIONS IN MYH7 AND MYBPC3 ASSESSED WITH CMR TISSUE TAGGING
    Guclu, Ahmet
    van der Velden, Jolanda
    Brouwer, Wessel P.
    van Rossum, Albert C.
    Germans, Tjeerd
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1062 - E1062
  • [22] Prevalence and Phenotypic Expression of Mutations in the MYH7, MYBPC3 and TNNT2 Genes in Families with Hypertrophic Cardiomyopathy in the South of Brazil: A Cross-Sectional Study
    Piva e Mattos, Beatriz
    Scolari, Fernando Luis
    Rodrigues Torres, Marco Antonio
    Simon, Laura
    de Freitas, Valeria Centeno
    Giugliani, Roberto
    Matte, Ursula
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2016, 107 (03) : 257 - 265
  • [23] Effect of Cis-Compound Variants in MYH7 on Hypertrophic Cardiomyopathy With a Mild Phenotype
    Zhang, Mo
    Sun, Xiaolu
    Wu, Guixin
    Wang, Dong
    Wang, Limei
    Zhang, Channa
    Zou, Yubao
    Wang, Jizheng
    Song, Lei
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 167 : 104 - 110
  • [24] Antisense oligonucleotides as a potential therapeutic strategy in hypertrophic cardiomyopathy caused by MYBPC3 variants
    Munteanu, S.
    Nicolas Rocamora, E. M.
    Martinez Perez, C.
    Bernabe Garcia, A.
    Nicolas Villaescusa, F. J.
    Gimeno Blanes, J. R.
    Arechavala Gomeza, V
    Sabater Molina, M.
    CARDIOVASCULAR RESEARCH, 2024, 120
  • [25] The significance of polymorphisms and intronic variants in MYBPC3: Pitfalls in genetic diagnosis of hypertrophic cardiomyopathy
    Frank-Hansen, R.
    Andersen, P. S.
    Havndrup, O.
    Bundgaard, H.
    Mckenna, W. J.
    Christiansen, M.
    EUROPEAN HEART JOURNAL, 2006, 27 : 951 - 951
  • [26] Cryptic Splice-Altering Variants in MYBPC3 Are a Prevalent Cause of Hypertrophic Cardiomyopathy
    Lopes, Luis R.
    Barbosa, Pedro
    Torrado, Mario
    Quinn, Ellie
    Merino, Ana
    Ochoa, Juan Pablo
    Jager, Joanna
    Futema, Marta
    Carmo-Fonseca, Maria
    Monserrat, Lorenzo
    Syrris, Petros
    Elliott, Perry M.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (03): : 165 - 167
  • [27] Description of a Cohort with a New Truncating MYBPC3 Variant for Hypertrophic Cardiomyopathy in Northern Spain
    Suarez, Natalia Fernandez
    Ubierna, Maria Teresa Viadero
    Basas, Jesus Garde
    de la Fuente, Maria Esther Onecha
    Lanza, Maria Teresa Amigo
    Gorria, Gonzalo Martin
    Perez, Adrian Rivas
    Guerrero, Luis Ruiz
    Gonzalez-Lamuno, Domingo
    GENES, 2023, 14 (04)
  • [28] Pathogenic Intronic Splice-Affecting Variants in MYBPC3 in Three Patients with Hypertrophic Cardiomyopathy
    Wood, Katherine A.
    Ellingford, Jamie M.
    Eden, James
    Thomas, Huw B.
    O'Keefe, Raymond T.
    Hopton, Claire
    Newman, William G.
    CARDIOGENETICS, 2021, 11 (02) : 73 - 83
  • [29] Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy
    Helms, Adam S.
    Thompson, Andrea D.
    Glazier, Amelia A.
    Hafeez, Neha
    Kabani, Samat
    Rodriguez, Juliani
    Yob, Jaime M.
    Woolcock, Helen
    Mazzarotto, Francesco
    Lakdawala, Neal K.
    Wittekind, Samuel G.
    Pereira, Alexandre C.
    Jacoby, Daniel L.
    Colan, Steven D.
    Ashley, Euan A.
    Saberi, Sara
    Ware, James S.
    Ingles, Jodie
    Semsarian, Christopher
    Michels, Michelle
    Olivotto, Iacopo
    Ho, Carolyn Y.
    Day, Sharlene M.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (05): : 396 - 405
  • [30] Key Value of RNA Analysis of MYBPC3 Splice-Site Variants in Hypertrophic Cardiomyopathy
    Singer, Emma S.
    Ingles, Jodie
    Semsarian, Christopher
    Bagnall, Richard D.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2019, 12 (01): : E002368